Get the Stockscreener App
5.72
6.32%
0.34
Pre-market:
5.68
-0.04
-0.70%
Bionano Genomics Inc Stock (BNGO) Forecast
The Bionano Genomics Inc (BNGO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.2153, representing a -78.75% decrease from the current price of $5.72. The highest analyst price target is $1.1916, and the lowest is $1.239.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BNGO Price Target
Average 1.5489
(-72.92% Downside)
Is Bionano Genomics Inc (BNGO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.39 | Neutral |
| STOCH(9,6) | 14.97 | Buy |
| STOCHRSI(14) | 48.23 | Neutral |
| MACD(12,26) | -2.3622 | Sell |
| ADX(14) | 22.26 | Neutral |
| William %R | -87.60 | Buy |
| CCI(14) | -22.12 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.566
Buy
|
6.2855
Sell
|
| MA20 |
8.7152
Sell
|
8.1634
Sell
|
| MA50 |
12.12
Sell
|
11.75
Sell
|
| MA100 |
16.40
Sell
|
17.41
Sell
|
| MA200 |
29.65
Sell
|
32.04
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, BNGO could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on BNGO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.39 indicates that BNGO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.97 indicates that BNGO is oversold. This indicates that BNGO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 48.23 indicates that BNGO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.26 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -22.12 indicates that BNGO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BNGO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bionano Genomics Inc financial reports and earnings history, Bionano Genomics Inc (BNGO) stock could reach $1.9928 by 2030, $2.4519 by 2040 and $5.5588 by 2050. See the projected annual prices until 2050 of the Bionano Genomics Inc stock below:
- Bionano Genomics Inc (BNGO) is expected to reach an average price of $0.0935 in 2035, with a high prediction of $0.2638 and a low estimate of $0.3735. This indicates an $-98.36% rise from the last recorded price of $5.72.
- Bionano Genomics Inc (BNGO) stock is projected to chart a bullish course in 2040, with an average price target of $2.5677, representing an $-55.11% surge from its current level. The forecast ranges from a conservative $2.3004 to a sky-high $2.4519.
- Our analysts predict Bionano Genomics Inc (BNGO) to jump -44.24% by 2045, soaring from $3.0947 to an average price of $3.1894, potentially reaching $3.2145. While $3.0947 is the low estimate, the potential upside is significant.
- Bionano Genomics Inc (BNGO) stock is expected to climb by 2050, reaching an average of $5.1574, a $-9.84% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.5588 and $5.5216, respectively, highlighting the market's uncertainty.
Bionano Genomics Inc Stock (BNGO) Year by Year Forecast
Bionano Genomics Inc Stock (BNGO) Price Forecast for 2025
Bionano Genomics Inc Stock (BNGO) is expected to reach an average price of $1.4977 in 2025, with a high prediction of $1.8588 and a low estimate of $1.1367. This indicates an -73.82% fall from the last recorded price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $1.2673 | $1.239 | $1.1916 | -77.84% |
| April, 2025 | $1.7645 | $1.5465 | $1.7376 | -69.15% |
| May, 2025 | $1.8536 | $1.865 | $1.8588 | -67.60% |
| June, 2025 | $1.8003 | $1.8087 | $1.7825 | -68.53% |
| July, 2025 | $1.6698 | $1.6449 | $1.6949 | -70.81% |
| August, 2025 | $1.5847 | $1.6508 | $1.6335 | -72.30% |
| September, 2025 | $1.2257 | $1.3608 | $1.2384 | -78.57% |
| October, 2025 | $1.5332 | $1.4143 | $1.4594 | -73.20% |
| November, 2025 | $1.3905 | $1.4529 | $1.4769 | -75.69% |
| December, 2025 | $1.51 | $1.4285 | $1.4372 | -73.60% |
Bionano Genomics Inc Stock (BNGO) Price Forecast for 2026
The predicted value for Bionano Genomics Inc (BNGO) in 2026 is set at an average of $7.452. Estimates vary from a peak of $13.80 to a trough of $1.1089, indicating an +30.28% surge from the present price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.4877 | $1.4878 | $1.4755 | -73.99% |
| February, 2026 | $1.4114 | $1.4589 | $1.4778 | -75.32% |
| March, 2026 | $6.4887 | $1.1089 | $7.5737 | +13.44% |
| April, 2026 | $11.68 | $5.5999 | $13.80 | +104.11% |
| May, 2026 | $7.1602 | $3.6976 | $11.49 | +25.18% |
| June, 2026 | $5.4453 | $5.0568 | $7.4664 | -4.80% |
| July, 2026 | $3.5867 | $2.4867 | $5.9024 | -37.30% |
| August, 2026 | $5.7918 | $3.3629 | $7.3318 | +1.25% |
| September, 2026 | $4.9931 | $4.0831 | $6.458 | -12.71% |
| October, 2026 | $4.5983 | $3.7657 | $5.0094 | -19.61% |
| November, 2026 | $4.1234 | $3.4008 | $4.6445 | -27.91% |
| December, 2026 | $3.8348 | $3.3785 | $4.3796 | -32.96% |
Bionano Genomics Inc Stock (BNGO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bionano Genomics Inc (BNGO) is $2.3305, with a high forecast of $4.6414 and a low forecast of $0.0196. This indicates an -59.26% decrease from the last price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4999 | $3.2573 | $3.8736 | -38.81% |
| February, 2027 | $2.785 | $2.725 | $4.6414 | -51.31% |
| March, 2027 | $1.8064 | $1.4401 | $2.8723 | -68.42% |
| April, 2027 | $0.9815 | $0.8615 | $1.8989 | -82.84% |
| May, 2027 | $0.5866 | $0.2541 | $0.9877 | -89.75% |
| June, 2027 | $0.393 | $0.1054 | $1.0028 | -93.13% |
| July, 2027 | $1.0931 | $0.1205 | $1.3516 | -80.89% |
| August, 2027 | $0.2682 | $0.2332 | $1.3256 | -95.31% |
| September, 2027 | $0.3196 | $0.0196 | $0.4194 | -94.41% |
| October, 2027 | $0.0247 | $0.0684 | $0.3584 | -99.57% |
| November, 2027 | $0.2498 | $0.0209 | $0.3098 | -95.63% |
| December, 2027 | $2.2512 | $0.0761 | $3.0012 | -60.64% |
Bionano Genomics Inc Stock (BNGO) Price Forecast for 2028
In 2028, Bionano Genomics Inc (BNGO) is projected to reach an average price of $1.2051, with a high projection of $2.3874 and a low estimate of $0.0229. This indicates an -78.93% fall from the last price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9863 | $0.9463 | $2.3874 | -82.76% |
| February, 2028 | $0.5314 | $0.4714 | $1.2588 | -90.71% |
| March, 2028 | $1.0728 | $0.4677 | $1.4765 | -81.25% |
| April, 2028 | $0.9779 | $0.8753 | $1.7616 | -82.90% |
| May, 2028 | $0.3093 | $0.2893 | $1.0667 | -94.59% |
| June, 2028 | $0.6444 | $0.1605 | $0.7944 | -88.73% |
| July, 2028 | $0.3995 | $0.3695 | $0.8532 | -93.02% |
| August, 2028 | $0.0709 | $0.0291 | $0.4758 | -98.76% |
| September, 2028 | $0.054 | $0.0229 | $0.1571 | -99.06% |
| October, 2028 | $0.3531 | $0.1049 | $0.3289 | -93.83% |
| November, 2028 | $0.2535 | $0.3575 | $0.3576 | -95.57% |
| December, 2028 | $0.4124 | $0.3203 | $0.3823 | -92.79% |
Bionano Genomics Inc Stock (BNGO) Price Forecast for 2029
The 2029 price forecast for Bionano Genomics Inc Stock (BNGO) is $1.9392 on average, with a high prediction of $3.8715 and a low estimate of $0.00682. This represents an -66.10% decrease from the previous price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4033 | $0.4083 | $0.3903 | -92.95% |
| February, 2029 | $2.1141 | $0.5148 | $3.8715 | -63.04% |
| March, 2029 | $2.3092 | $2.0304 | $3.2404 | -59.63% |
| April, 2029 | $1.3043 | $1.2143 | $2.3055 | -77.20% |
| May, 2029 | $0.4157 | $0.3031 | $1.4106 | -92.73% |
| June, 2029 | $0.8008 | $0.312 | $0.9145 | -86.00% |
| July, 2029 | $1.0559 | $0.5133 | $1.4359 | -81.54% |
| August, 2029 | $0.3773 | $0.3297 | $1.3322 | -93.40% |
| September, 2029 | $0.3624 | $0.2498 | $0.5561 | -93.66% |
| October, 2029 | $0.2938 | $0.2538 | $0.5787 | -94.86% |
| November, 2029 | $0.0289 | $0.00682 | $0.4301 | -99.50% |
| December, 2029 | $1.583 | $0.0252 | $1.033 | -72.33% |
Bionano Genomics Inc Stock (BNGO) Price Forecast for 2030
Bionano Genomics Inc Stock (BNGO) is expected to reach an average price of $3.0825 in 2030, with a high forecast of $4.1197 and a low forecast of $2.0453. This signifies an -46.11% decrease from the last price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.1452 | $2.0453 | $1.9928 | -62.50% |
| February, 2030 | $2.3028 | $2.5077 | $2.3826 | -59.74% |
| March, 2030 | $2.5899 | $2.3449 | $2.2675 | -54.72% |
| April, 2030 | $3.4196 | $3.0072 | $2.9621 | -40.22% |
| May, 2030 | $4.1168 | $3.8145 | $4.0868 | -28.03% |
| June, 2030 | $3.8645 | $3.9345 | $4.1197 | -32.44% |
| July, 2030 | $3.7438 | $3.7938 | $3.8615 | -34.55% |
| August, 2030 | $3.6186 | $3.6336 | $3.6613 | -36.74% |
| September, 2030 | $3.4134 | $3.4334 | $3.541 | -40.33% |
| October, 2030 | $3.4906 | $3.4283 | $3.4632 | -38.98% |
| November, 2030 | $3.9905 | $3.4981 | $3.3955 | -30.24% |
| December, 2030 | $4.1583 | $4.0227 | $3.9802 | -27.30% |
10.10%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):